好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Dalfampridine Treatment in Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Neuro-ophthalmology/Neuro-otology
P5 - (-)
202
Authors/Disclosures
Mark L. Moster, MD, FAAN (Neuro-Ophthalmology -Wills Eye Hospital)
PRESENTER
Dr. Moster has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Gensight . Dr. Moster has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viridian. Dr. Moster has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Kilcoyne and Nesbitt.
Robert C. Sergott, MD (Wills Eye Hospital) Dr. Sergott has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Sergott has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Sergott has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen.
No disclosure on file